Folsom couple urges company to reconsider cancer drug trial decision

FOLSOM, Calif. – A third pharmaceutical company has turned down a Folsom couple request for a clinical cancer drug trial.

Merck, based in New Jersey, last week denied Keith Knapp's request for a compassionate use trial of an anti-PD1 drug that he believes may give wife Mikaela a chance to live.

"We can't just let that serve as the final answer," Knapp said.

Doctors have diagnosed Mikaela's form of kidney cancer as terminal.


Folsom man fighting for clinical cancer drug trial to keep his wife alive

More than 400,000 people have signed a petition in support of the couple's efforts.

Knapp is hoping for 500,000 signatures on the petition by Friday, when he plans to fly back east to drop off all of those signatures, individually printed, at Merck's headquarters.

Even though Merck has said no, Knapp is hoping this will help convince leaders at the company to reconsider.

"We're hopeful, we're never going to give up on this, no matter how dire the situation gets," Knapp said. "She never just wants to get into a spot where we just give up on this campaign."


To find out more about Facebook commenting please read the
Conversation Guidelines and FAQs

Leave a Comment